← Back to Search

Behavioral Intervention

Remote Prenatal Care for Pregnancy

N/A
Recruiting
Led By Mary Messito, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥18 years
Speak English or Spanish fluently
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months (6-14 weeks postpartum)
Awards & highlights

Study Summary

This trial aims to test if remote prenatal care can help pregnant people with diet, lifestyle, social factors, and pregnancy outcomes.

Who is the study for?
This trial is for English or Spanish-speaking pregnant individuals in their first trimester, who are at least 18 years old and plan to get prenatal and pediatric care at Bellevue Hospital. They must have a smartphone with internet and be able to consent. Those with severe illnesses, living in shelters, or undergoing substance abuse treatment cannot join.Check my eligibility
What is being tested?
The study is examining the effectiveness of StEP:Prenatal—a remote program focused on improving diet, lifestyle behaviors, social health factors—and its impact on pregnancy outcomes compared to standard prenatal care.See study design
What are the potential side effects?
Since this trial involves non-medical interventions focusing on education and lifestyle changes through an mHealth platform rather than drugs or medical procedures, significant side effects are not anticipated.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I speak English or Spanish fluently.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months (6-14 weeks postpartum)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months (6-14 weeks postpartum) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Daily servings of dairy (total milk cup equivalents)
Daily servings of fruits (cup equivalents)
Daily servings of protein foods (ounce equivalents)
+8 more
Secondary outcome measures
Family Resilience score
Generalized Anxiety Disorder-7 score
Gestational weight gain
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Routine Care + StEP:PrenatalExperimental Treatment2 Interventions
Participants will receive routine care and up to 8 StEP:Prenatal sessions. Routine care will follow through the post-partum period.
Group II: Routine CareActive Control1 Intervention
Participants will receive routine care during pregnancy and the post-partum period.

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,369 Previous Clinical Trials
840,298 Total Patients Enrolled
United States Department of Agriculture (USDA)FED
97 Previous Clinical Trials
350,462 Total Patients Enrolled
Mary Messito, MDPrincipal InvestigatorNYU Langone Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age threshold for this clinical research exceeding fifty years?

"Per the study's eligibility mandate, any person 18 years old or older and under 99 can apply for this clinical trial."

Answered by AI

Could I qualify to participate in this research endeavor?

"To join this medical trial, potential participants must be of childbearing age (18-99) and expecting a baby. A total of 300 individuals will have the opportunity to participate in this study."

Answered by AI

Are there presently vacancies in this trial for participants?

"Contrary to expectation, clinicaltrials.gov reveals that this trial is not actively searching for participants at present; the study was first introduced on October 23rd 2023 but has since been revised on the 11th of October. Nonetheless, there are 86 other research projects currently recruiting individuals into their trials."

Answered by AI
~200 spots leftby Apr 2026